NCT02000401

Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain

To Evaluate the Efficacy, Tolerability, and Safety of Intranasal Ketorolac Tromethamine (Sprix) as an Option for Acute (up to 5 Days) Pain Management Adult Interstitial Cystitis Patients Experiencing a Flare of Pain

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Citrus Valley Medical Research, Inc. · Academic / Other
• Sex: Female
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

Intranasal Ketorolac tromethamine has a potential role as a short term pain management tool for Interstitial Cystitis without the risk and undesirable effects of narcotics.

Conditions

• Interstitial Cystitis

Interventions

Type	Name	Description
DRUG	Ketorolac Tromethamine

Timeline

• Start date: 2012-05-01
• Primary completion: 2013-07-01
• Completion: 2013-07-01
• First posted: 2013-12-04
• Last updated: 2013-12-04

Locations

1 site across 1 country: United States